Chemical inhibitors of copine 5 offer a range of mechanisms by which the activity of this protein can be hindered. Bisindolylmaleimide I targets protein kinase C (PKC), a kinase that, when active, may enhance the phosphorylation state of various proteins, including copine 5. By inhibiting PKC, Bisindolylmaleimide I can thus prevent the phosphorylation and subsequent activation of copine 5. Similarly, Genistein acts by inhibiting tyrosine kinases, which are responsible for the phosphorylation of proteins on tyrosine residues. This inhibition can lead to a reduction in copine 5 phosphorylation levels, thereby decreasing its activity. LY294002 and Wortmannin both inhibit phosphoinositide 3-kinases (PI3K), enzymes involved in cellular signaling pathways that can activate copine 5. Their action curtails the PI3K signaling, which can lead to a decrease in copine 5 activation.
Additionally, the MEK inhibitors PD98059 and U0126 disrupt the MAPK/ERK pathway, a pathway that is involved in the regulation of a wide variety of cellular processes, including those that may activate copine 5. By inhibiting MEK, PD98059 and U0126 can lead to reduced copine 5 activity. SB203580 and SP600125 target the p38 MAPK and JNK pathways, respectively, both of which might be connected to the regulation of copine 5 activity. SB203580 inhibits p38 MAPK, potentially affecting the activation of copine 5 that relies on signals from the MAPK pathway. SP600125 inhibits JNK, which can decrease the activity of transcription factors that regulate copine 5, leading to its inhibition. PF-573228 inhibits FAK, which is involved in integrin signaling pathways, and by doing so, it can influence the signaling pathways that activate copine 5. Y-27632 targets Rho-associated protein kinase (ROCK), which is implicated in various signaling pathways, and by inhibiting ROCK, it can downregulate signaling pathways involving copine 5, leading to its inhibition. Lastly, Gö 6983 inhibits PKC isozymes, which can also reduce phosphorylation events necessary for the activity of copine 5, thereby inhibiting the protein. Each of these chemicals acts to decrease the function of copine 5 through specific inhibition of signaling pathways or enzymatic activities that are crucial for the activation and function of copine 5.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits protein kinase C (PKC), which could reduce the phosphorylation of copine 5, leading to its inhibition. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, potentially reducing the phosphorylation of copine 5, resulting in inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which is upstream in signaling pathways that can activate copine 5, thus inhibiting it. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is part of the MAPK/ERK pathway; copine 5's function can be inhibited due to reduced pathway activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially reducing copine 5 activation that relies on MAPK pathway signals. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family tyrosine kinases, could disrupt downstream signaling affecting copine 5 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially reducing the activity of transcription factors that regulate copine 5 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2 in the ERK pathway, potentially leading to decreased activation of copine 5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, potentially decreasing the activation of copine 5 due to reduced PI3K signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which can downregulate signaling pathways involving copine 5, leading to its functional inhibition. | ||||||